Abbott Laboratories (ABT) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $89.65 +0.54%
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
CRMT, REPL, ANIX, More
Revenue Growth %: +9.8%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
CRMT, REPL, ANIX, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q4 EPS of $1.51, $0.01 better than the analyst estimate of $1.50. Revenue for the quarter came in at $10.8 billion versus the consensus estimate of $10.58 billion.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Abbott Laboratories sees FY2013 ongoing EPS of $1.98-2.04, which the company called "strong."
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Citizens Upgrades EPR Properties (EPR) to Market Outperform
- Barclays Upgrades Avanza Bank Holding AB (AZA:SS) to Overweight
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
